A Case Study from the Chemistry Core of the Pittsburgh Molecular Library Screening Center: The Polo-like Kinase Polo-Box Domain (Plk1- PBD)

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 13, 2009-09 ,pp. : 1194-1205

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Analysis of Pyridopyrimidine-based Polo Like Kinase 2 (PLK2) Inhibitors: Examining the Structural Basis for Anticancer Activity

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 5, 2017-04 ,pp. : 581-596

Bentham Science Publishers

Access to resources Recommend Favorite

Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma

By  

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1347-1350

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Discovery of Polo-like Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 181-197

Bentham Science Publishers

Access to resources Recommend Favorite

Polo-Like Kinases Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 3937-3948

Bentham Science Publishers

Access to resources Recommend Favorite